Keywords
Nanomedicines
Gene vaccines
Regulatory issues
Safety assessment
Intellectual property rights
Ethical considerations
List of AbbreviationsADR
Adverse Drug Reactions
APCs
Antigen Presenting Cells
COVID-19
Corona Virus Disease 2019
CTAB
Cetyltrimethylammonium Bromide
CTLs
Cytotoxic T-lymphocytes
cryo-TEM
Cryo-Transmission Electron Microscopy
DOTAP
Dioleoyl-3-Trimethylammonium Propane
E1
E1A, E1B E2, E3, E4, Early Regions of Adeno Virus
E4ORF3
E4ORF6, Early Region and Open Reading Frames of Adeno Virus
EMA
European Medicines Agency
FAS-ligand
Ligand for Subgroup of TNF-R
FDA
Food and Drug Administration
FFP
Freedom From Progression
HSPGs
Heparan sulfate proteoglycans
ISGF3
Interferon-Stimulated Gene Factor 3
LPHNs
Lipid-Polymer Hybrid Nanoparticles
MHC
Major Histocompatibility Complex
MRI
Magnetic Resonance Imaging
mRNA
Messenger Ribonucleic Acid
NF-κB
Nuclear Factor Kappa B
NLCs
Nanostructured Lipid Carriers
NSCLC
Non-Small Cell Lung Cancer
PDT
Photodynamic Therapies
PEG
Poly-(ethylene glycol)
PEG-PE
Poly-(ethylene glycol)-phosphatidylethanolamine
PFS
Progression Free Survival
PHLNPs
Polymer-lipid hybrid nanoparticles
PLGA
Poly-D,L-lactide-co-glycolide
PTT
Photothermal Treatments
pRB
Retinoblastoma Protein
RES
Retinal Endothelial System
RFS
Recurrence-Free Survival
SANS
Small Angle Neutron Scattering
SAXS
Small Angle X-Ray Scattering
SCLC
Small Cell Lung Cancer
SLNs
Solid Lipid Nanoparticles
TERT
Telomerase Reverse Transcriptase
TNF-α
Tumour Necrosis Factor
留言 (0)